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Guinea-Bissau in West Africa has the highest prevalence of human immunodeficiency virus (HIV)-2 infection in the world,
but recently the HIV-1 prevalence increased rapidly with the subsequent appearance of HIV-1 and HIV-2 dual infections.
Information about the genetic subtypes of HIV in the region is limited. Therefore, we characterized the env V3 region of HIV-1
and HIV-2 variants through direct DNA sequencing of peripheral blood mononuclear cell samples from 18 individuals with
HIV-1 only and 9 individuals with dual infection. Phylogenetic analyses of these new sequences and database sequences
from other West African countries showed that all HIV-1 and HIV-2 sequences from singly as well as dually infected
individuals, except one, clustered among HIV-1 subtype A and HIV-2 subtype A, respectively. Importantly, a majority of the
HIV-1 sequences from Guinea-Bissau and neighbouring countries were closely related with the isolates IbNG, DJ263, and
DJ264, which share a common subtype A/G recombination pattern. Analysis of pol gene sequences from selected HIV-1
variants showed that “IbNG-like” viruses in Guinea-Bissau are also recombinant, indicating that the HIV-1 epidemic in
Guinea-Bissau and neighbouring countries is dominated by an epidemic spread of a distinct subtype A/G recombinant, which
is strikingly similar to the epidemic spread of a subtype A/E recombinant in Southeast Asia. Furthermore, the HIV-1 and HIV-2
variants carried by individuals with dual infection were intermixed with variants from singly infected individuals, indicating
that variants involved in dual and single infections have common epidemiological histories. © 1999 Academic Press
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The distribution and spread of HIV subtypes in Africa
re heterogeneous and incompletely known. All major
ubtypes of the human immunodeficiency virus type 1
HIV-1) group M (i.e., subtypes A–H) and of HIV-2 have
een detected on the continent (Gao et al., 1994; Chen et
l., 1997; Janssens et al., 1997). However, the geographic
istribution of the HIV subtypes shows large heteroge-
eity. In some regions, only one or two subtypes are
revalent, whereas in other regions, several subtypes
oexist (Gao et al., 1994; Delaporte et al., 1996; Janssens
t al., 1997). The largest variety of circulating HIV-1 sub-
ypes has been found in central and equatorial Africa,
hus subtypes A through H of HIV-1 group M as well as
roups O and N have been detected in the area including
he Central African Republic, Cameroon, and Gabon
Delaporte et al., 1996; Janssens et al., 1997; Simon et al.,
998). HIV-2 is mainly confined to West Africa, where all
escribed subtypes (A through F) have been detected
Gao et al., 1994; Chen et al., 1997). A recent study in
uinea-Bissau indicated that a majority of HIV-2 singly
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312nfected patients carry subtype A (Norrgren et al., 1997).
owever, the picture is still incomplete, and from some
arts of the continent, data about the subtype distribution
f HIV-1 and HIV-2 are lacking. Furthermore, it is still not
lear whether there are subtype-specific differences in
he rate of transmission or disease progression. HIV
ubtype variations may also have implications for HIV
accine development, diagnostic testing using antibody
etection as well as nucleic acid amplification tech-
iques, and the occurrence of antiretroviral drug resis-
ance. It is therefore important to increase our knowl-
dge about the HIV subtype distribution in Africa.
Guinea-Bissau in West Africa has the highest preva-
ence of HIV-2 infection in the world (De Kock et al., 1993),
ut until recently, the prevalence of HIV-1 infection was
ery low. However, during the past few years, HIV-1 has
een introduced and rapidly spread, which has resulted
n a mixed epidemic. In the capital, Bissau, in 1997, 2.0%
f the pregnant women were HIV-1 positive, 4.6% were
IV-2 positive, and 0.5% were HIV-1 and HIV-2 dually
nfected (Poulsen et al., 1993; Norrgren et al., 1995, 1999).
ittle is known about the molecular characteristics of
irus variants carried in HIV-1 and HIV-2 dually infected
ndividuals.
The objectives of this study were to increase ournowledge about the virus variants that circulate in
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313MOLECULAR CHARACTERIZATION OF HIV-1 AND -2uinea-Bissau and their relationships to HIV in other
est African countries and to study whether HIV se-
uences obtained from HIV singly and dually infected
ndividuals are genetically distinct.
RESULTS
linical and laboratory characteristics of HIV-1-,
IV-2-, and dually infected individuals
Basic characteristics of the 18 HIV-1 singly infected
nd the 9 HIV-1 and HIV-2 dually infected individuals are
ummarized in Table 1. Details about the HIV-2 singly
T
Summary of Clinical and Laboratory Information Regarding the
Subject Sample date
Serological
diagnosis Age Sex
CD4 cou
(3106/lit
23 Mar 1995 HIV-1 38 M 328
41 May 1994 HIV-1 37 M 429
48 Nov 1995 HIV-1 41 M 616
98 Mar 1995 HIV-1 34 M 468
417 Mar 1995 HIV-1 43 M 208
418 Nov 1995 HIV-1 51 M 256
980 Jan 1996 HIV-1 41 M 474
1070 Feb 1996 HIV-1 27 M 136
1539 Jan 1996 HIV-1 26 M 369
K1451 Oct 1995 HIV-1 NA M 13
K1452 Oct 1995 HIV-1 NA F 312
K1482 Oct 1995 HIV-1 NA F 310
K1487 Oct 1995 HIV-1 NA F 562
K1537 Nov 1995 HIV-1 NA F 642
A23 Oct 1995 HIV-1 33 M 748
A70 Oct 1995 HIV-1 52 M NA
B8 Sep 1994 HIV-1 30 M 412
B40 Jun 1995 HIV-1 39 M 70
138 Jul 1995 HIV-1 1 2
dual
42 F 595
1315 Oct 1995 HIV-1 1 2
dual
31 M 77
K1484 Oct 1995 HIV-1 1 2
dual
22 F 84
K1485 Oct 1995 HIV-1 1 2
dual
30 M 336
B26 Dec 1994 HIV-1 1 2
dual
60 F 295
B28 Jan 1995 HIV-1 1 2
dual
43 F 390
B60 Jul 1995 HIV-1 1 2
dual
32 F 276
B94 Aug 1997 HIV-1 1 2
dual
38 F 806
B100 Aug 1995 HIV-1 1 2
dual
42 F 201
Note. NA, not available. PCS, prospective cohort study.
a Positive by diagnostic PCR, but negative in the sequencing proced
b Negative by both diagnostic PCR and in the sequencing procedurenfected individuals who were included as controls have ceen presented previously (Norrgren et al., 1997). All
ndividuals who displayed single HIV-1 antibody reactiv-
ty were also singly positive by PCR. Similarly, eight
ndividuals who showed dual serological reactivity
gainst both HIV-1 and HIV-2 also showed dual PCR
eactivity. One individual (PK1484) with dual serological
eactivity was only PCR positive against HIV-1. Another
ndividual (P1315) had HIV-1 and HIV-2 dual reactivity by
ntibody assays as well as by diagnostic PCR, but at-
empts to obtain HIV-2 V3 sequences failed. The clinical
nd immunological status of the HIV-1-infected individu-
ls ranged from healthy with normal CD41 lymphocyte
1
uals Included in the Study of HIV Subtypes in Guinea-Bissau
HIV-1 V3
genotype
HIV-1 RT
genotype
HIV-2 V3
genotype
Clinical and epidemiological
information (seroconversion)
A (IbNG) PCS, healthy (1990)
A PCS, healthy (1990)
A (IbNG) PCS, healthy (1994)
A (IbNG) PCS, healthy (1991)
A (IbNG) PCS, weight loss,
generalized pruritus
A (IbNG) G PCS, healthy (1991)
A (IbNG) G PCS, healthy (1993)
A (IbNG) PCS, healthy (1993)
A (IbNG) PCS, healthy (1994)
A (IbNG) Outpatient
A (IbNG) Outpatient
A (IbNG) G Outpatient
A (IbNG) Outpatient
A (IbNG) Outpatient
A (IbNG) Hospitalized with abdominal
tumour
B Hospitalized with AIDS
A G Tuberculosis
A (IbNG) Tuberculosis
A (IbNG) A PCS, AIDS
A (IbNG) (negative)1 PCS, healthy
A (IbNG) G (negative)2 Outpatient
A (IbNG) G A Outpatient
A (IbNG) A Tuberculosis
A A Tuberculosis
A (IbNG) A Tuberculosis
A (IbNG) A Tuberculosis
A A A TuberculosisABLE 1
Individ
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ure.ounts to symptomatic with severely depressed CD4
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314 ANDERSSON ET AL.ounts. Eight of the nine individuals with dual infection
ere symptomatic but had normal or only moderately
epressed CD41 counts.
enetic subtypes of HIV-1 and HIV-2
n Guinea-Bissau
The subtype of the HIV-1 and HIV-2 variants carried by
FIG. 1. Phylogenetic tree of HIV-1 env V3 sequences (408 bp) obtained
ndividuals from Guinea-Bissau. E, Sequences from 9 HIV-1 and HIV-2
ubtype A (Theoretical Biology and Biophysics Group, 1997). <, IbN
orrespond to database sequences originating from West and Centra
elected sequence clusters is also shown.he study subjects was determined by phylogenetic anal- Hsis of DNA sequences from the V3 domain of the env
ene (Figs. 1 and 2). Samples from a total of 18 HIV-1
ingly infected persons were investigated, and all except
ne clustered together with subtype A sequences. The 9
ndividuals with dual infection also carried HIV-1 variants
f subtype A (Fig. 1). One hospitalized patient with ac-
uired immune deficiency virus (AIDS) was infected with
e neighbor-joining method. F, Sequences from 18 HIV-1 singly infected
infected individuals from Guinea-Bissau. ,, Reference sequences for
viruses (IbNG, DJ263, and DJ264). Remaining unlabeled sequences
as described in Materials and Methods. The bootstrap support forwith th
dually
G-like
l AfricaIV-1 of subtype B (Fig. 1). To rule out PCR contamination
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315MOLECULAR CHARACTERIZATION OF HIV-1 AND -2nd other laboratory artifacts of this HIV-1 subtype B
ample, we also sequenced a part of the p17 domain of
he gag gene. These sequences also clustered with
ubtype B sequences and thus supported the analysis
ased on env gene sequences (not shown).
Figure 2 shows the phylogenetic tree for the HIV-2 vari-
nts constructed using DNA sequences of a 273-bp frag-
ent encompassing the V3 loop of HIV-2. The analysis
ncluded the seven new HIV-2 sequences from the dually
nfected individuals, previously published sequences from
uinea-Bissau (Norrgren et al., 1997), and reference se-
FIG. 2. Phylogenetic tree of HIV-2 env V3 sequences (273 bp) obta
nfected individuals from Guinea-Bissau. E, Sequences from 7 HIV-
equences for HIV-2 subtype A. Remaining unlabeled sequences corre
ootstrap support for selected sequence clusters is also shown.uences from the Los Alamos database. The HIV-2 variants darried by the dually infected individuals clustered with
IV-2 sequences of subtype A. As reported previously (Nor-
gren et al., 1997), all HIV-2 singly infected individuals (20
symptomatic HIV-2 carriers and 11 AIDS patients) also
arried HIV-2 variants of subtype A.
IV-1IbNG-like subtype A/G recombinants dominate the
IV-1 epidemic in Guinea-Bissau and other West
frican countries
The phylogenetic analyses were also used for more
ith the neighbor-joining method. F, Sequences from 31 HIV-2 singly
HIV-2 dually infected individuals from Guinea-Bissau. ,, Reference
to database sequences as described in Materials and Methods. Theined w
1 and
spondetailed molecular epidemiology. Thus we performed
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316 ANDERSSON ET AL.hylogenetic analyses that included additional subtype A
nd G sequences. These sequences were obtained from
he Los Alamos Database in December 1998 using the
earch tools at their website and included all available
IV-1 V3 sequences from other West African countries
i.e., Benin, Burkina Faso, the Ivory Coast, the Gambia,
hana, Nigeria, and Senegal, as well as representative
ubtype A sequences from Central and East Africa; no
equences were available from Cape Verde, Guinea,
iberia, Mali, Mauritania, Niger, Sierra Leone, or Togo).
n addition, we included sequences from the isolates
bNG, DJ263, and DJ264 that recently were shown to
ave an identical subtype A/G recombination pattern
ith the env gene derived from subtype A (Carr et al.,
998). Other subtype A/G recombinants were also in-
luded.
The analyses showed that almost all sequences ob-
ained from West African countries clustered with sub-
ype A sequences. Furthermore, three sequence clusters
ould be identified within subtype A. Interestingly, these
equence clusters corresponded closely with the geo-
raphical origin of the viruses. Thus 22 of the 26 new
ubtype A sequences from Guinea-Bissau clustered to-
ether with sequences from the IbNG, DJ263, and DJ264
solates (Fig. 1). This cluster also included a majority of
he sequences originating from the other West African
ountries mentioned (i.e., 13 of 20 sequences from Benin,
0 of 14 from the Ivory Coast, 5 of 6 from Ghana, and 1 of
from Nigeria). The second cluster included all four
eference sequences of subtype A (U455, SF170, KENYA,
nd 92UG037), as well as all other sequences of Central
nd East African origin (i.e., Uganda, Central African
epublic, Gabon, Rwanda, and Kenya) and one se-
uence from the Ivory Coast. The third cluster contained
he remaining four subtype A sequences from Guinea-
issau, as well as two from Benin, one from Ghana, and
hree from the Ivory Coast. The bootstrap support for the
hree sequence clusters within subtype A was relatively
ow, suggesting that exact branching patterns require
urther study.
Because of the low bootstrap values and the fact that
he IbNG, DJ263, and DJ264 isolates are subtype A/G
ecombinants, we sequenced a region corresponding to
he first half of the reverse transcriptase (RT) from seven
f our HIV-1-infected patients (Table 1). In this region,
bNG, DJ263, and DJ264 cluster with subtype G se-
uences (Carr et al., 1998). Phylogenetic analysis
howed that with high bootstrap support, all five viruses
hat had an “IbNG-like” V3 sequence clustered with sub-
ype G sequences in the RT domain and that they were
ore closely related to IbNG, DJ263, and DJ264 than to
ther subtype G sequences (Fig. 3). These results
trongly indicate that a majority of viruses whose V3
equences cluster together with IbNG (i.e., most West
frican variants) share the same subtype A/G recombi-
ation pattern. The RT analysis also included sequences from two patients (TB8 and TB100), whose V3 sequences
ell outside the IbNG cluster. One of them, TB100, clus-
ered with subtype A sequences also in the RT gene,
ndicating that the virus carried by this patient was non-
ecombinant. The other, TB8, displayed an IbNG-like sub-
ype G sequence in RT, suggesting that this virus may
epresent a recombination between a “classic” subtype A
ariant and an IbNG-like variant. We are attempting to
btain additional samples from this individual to confirm
he finding and, if so, to sequence the entire genome of
his virus.
IV-1 and HIV-2 variants carried by singly and dually
nfected individuals have common histories
We also investigated whether HIV-1 and HIV-2 variants
arried by individuals with single infection and with dual
nfection had distinct histories. These analyses showed
hat the HIV-1 sequences obtained from individuals with
ual infection were intermixed with those from individu-
ls with single HIV-1 infection (Fig. 1). Similarly, the HIV-2
equences from singly and dually infected individuals
id not form distinct subclusters within subtype A but
ere intermixed in the tree (Fig. 2). This indicates that the
IV-1 and HIV-2 variants found in dually infected individ-
als represent a random sample of the variants present
n Guinea-Bissau and suggests that dual infection does
ot require specific viral characteristics.
DISCUSSION
In the present study, we analyzed HIV variants ob-
ained from 18 HIV-1 singly infected and 9 HIV-1 and
IV-2 dually infected individuals from Guinea-Bissau. All
IV-1 variants, except one, were found to have V3 do-
ains derived from genetic subtype A of HIV-1. However,
he analyses indicated that a majority of these variants
ere subtype A/G recombinants that shared ancestry
ith the IbNG isolate, which is the prototype for a distinct
ubtype A/G recombinant (Carr et al., 1998, 1999). The
IV-2 variants carried by dually infected individuals were
ll of HIV-2 subtype A. The HIV-1 and HIV-2 variants
arried by dually infected individuals did not display any
istinct genetic or phylogenetic characteristics from
hose carried by singly infected individuals.
The finding that almost all HIV-1 variants in Guinea-
issau have V3 domains that cluster together with sub-
ype A sequences is in agreement with existing, albeit
imited, data from other parts of West Africa (Janssens et
l., 1997; Carr et al., 1999; Brandful et al., 1998; Oelrich et
l., 1998; Peeters et al., 1998; Ellenberger et al., 1999).
owever, an important conclusion from our analyses is
hat a majority of the infections in West Africa appear to
e caused by the epidemic spread of a distinct subtype
/G recombinant form of HIV-1. Thus an absolute major-
ty of the viruses from Guinea-Bissau and the variants
rom neighbouring countries available through the Los
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317MOLECULAR CHARACTERIZATION OF HIV-1 AND -2lamos database cluster most closely together with
hree viruses, namely IbNG, DJ263, and DJ264, which
ecently were shown to have a shared subtype A/G
ecombinant structure (Carr et al., 1998). To formally
rove that other viruses that fall in the IbNG cluster also
re subtype A/G recombinants, we sequenced a portion
f the pol gene from selected viruses from Guinea-Bis-
au. This region is derived from subtype G in IbNG,
J263, and DJ264. We found that viruses that clustered
FIG. 3. Phylogenetic tree of HIV-1 RT (509 bp) obtained with the nei
rom Guinea-Bissau. E, Sequences from 3 HIV-1 and HIV-2 dually infecte
(Theoretical Biology and Biophysics Group, 1997). <, IbNG-like viruse
atabase sequences originating from West and Central Africa as descr
lusters is also shown.ith IbNG in V3 displayed a subtype G genotype in the pol gene. This indicates that a majority of members of the
bNG cluster are subtype A/G recombinants. Importantly,
he subtype G pol gene sequences from Guinea-Bissau
ere more closely related to the pol genes of IbNG,
J263, and DJ264 than they were to other subtype G pol
enes. Together these data indicate that the HIV-1 epi-
emic in West Africa is dominated by the epidemic
pread of a distinct subtype A/G recombinant form of
IV-1 that is different than the HIV-1 subtype A strains
oining method. F, Sequences from 5 HIV-1 singly infected individuals
iduals from Guinea-Bissau. ,, Reference sequences for subtype A and
G, DJ263, and DJ264). Remaining unlabeled sequences correspond to
Materials and Methods. The bootstrap support for selected sequenceghbor-j
d indiv
s (IbN
ibed inrevailing in East Africa. This information may have im-
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318 ANDERSSON ET AL.ortant implications for our future understanding of the
atural history of HIV infection and immune responses
nd for HIV vaccine development. It should also be noted
hat two other recent papers indicate that the epidemics
n the Ivory Coast and Cameroon are dominated by
IbNG-like” viruses even though the authors do not com-
ent on this or the fact that IbNG is a subtype A/G
ecombinant (Takehisa et al., 1998; Ellenberger et al.,
999). The genetic distances between individual mem-
ers of the IbNG cluster suggest that these variants are
escendants of a recombination event that did not occur
ery recently. Carr et al. (1998, 1999) suggested that
hese “IbNG-like” viruses should be considered a distinct
ubtype and drew parallels to the subtype A/E recombi-
ant that has spread epidemically in Southeast Asia.
hey suggest that these epidemiologically successful
ecombinants should be called “circulating recombinant
orms” (CRFs) to distinguish them from other recombi-
ants (Carr et al., 1999). Furthermore, they propose that
hese forms should be distinguished by associating the
RF with the name of the first full-length viral sequence
f that form, for instance, AG(IbNG).
The prevalence and incidence of HIV-1 have recently
ncreased in Guinea-Bissau. Our study indicates that
IV-1 has independently been introduced into the coun-
ry on several occasions because many of the se-
uences from Guinea-Bissau were separated by se-
uences from other West African countries. However, the
hylogenetic analyses also provided evidence of the
ocal spread of HIV-1 within Guinea-Bissau. Thus it was
ossible to identify three sequence clusters, which con-
ained only sequences from Guinea-Bissau separated by
hort branches.
We also investigated whether the variants carried by
IV-1 and HIV-2 dually infected individuals were distinct
rom those carried by HIV-1 or HIV-2 singly infected
ndividuals. However, we found that this was not the
ase because the sequences from singly and dually
nfected individuals were intermixed in both the HIV-1
nd HIV-2 trees. Thus our study suggests that no specific
haracteristics are required for dual infection. However,
t should be pointed out that our sample is small, and we
annot formally exclude the possibility that certain ge-
etic variants of HIV-1 or HIV-2 may be better adapted for
ual infection than others. Data on genetic characteriza-
ion of HIV-1 and HIV-2 in dually infected individuals are
carce. HIV strains from five patients in India with PCR-
onfirmed dual infection were described, but no data on
equences from singly infected persons in the same
opulation were reported (Grez et al., 1994). Three PCR-
onfirmed dually infected patients in Mali were included
n a phylogenetic analysis, but their positions were not
pecifically indicated (Peeters et al., 1998). To our knowl-
dge, the data presented here are the first where HIV
equences from singly and dually infected persons fromhe same area are analyzed concomitantly. In this con- fext, it should be mentioned that Travers et al. (1995)
eported that HIV-2 infection appeared to protect from
ubsequent HIV-1 infection in Senegal. This finding has
ot been possible to confirm in similar studies in Guinea-
issau (Norrgren et al., 1999; Olav Larsen, personal com-
unication) and Ivory Coast (Wiktor et al., 1999), but it is
ossible that these differences may be attributed to ge-
etic differences between HIV variants in Senegal and
hese neighbouring countries.
In conclusion, we found that the HIV-1 epidemic in
uinea-Bissau and neighbouring West African countries
s dominated by an HIV-1IbNG-like subtype A/G recombi-
ant [CRF AG(IbNG)]. Furthermore, the HIV-1 and HIV-2
ariants carried by individuals with dual infection were
ntermixed with variants from singly infected individuals,
hich indicates that the variants involved in dual and
ingle infections have common epidemiological histo-
ies. These data will form the basis for further studies on
he epidemiology and natural history of HIV-1 and HIV-2
n Guinea-Bissau and other parts of West Africa.
MATERIALS AND METHODS
tudy population
Blood samples were obtained from 27 persons who
ere taking part in different HIV studies in Guinea-Bis-
au: 11 were HIV carriers (9 HIV-1 infected and 2 HIV-1
nd HIV-2 dually infected) who were enrolled in a pro-
pective cohort study; 7 were outpatients at National
ospital (Sima˜o Mendes) in Bissau (5 HIV-1 singly in-
ected and 2 HIV-1 and HIV-2 dually infected); 2 were
ospitalized at the same hospital (both HIV-1 singly in-
ected); and 7 were patients being treated at a tubercu-
osis hospital in Bissau (2 HIV-1 singly infected and 5
IV-1 and HIV-2 dually infected). The group of HIV-1
ingly infected persons consisted of a total of 8 asymp-
omatic HIV carriers, all from the prospective cohort
tudy and with known seroconversion date (seroconver-
ion between 1990 and 1994). Nine inpatients at National
ospital and the tuberculosis hospital fulfilled the World
ealth Organization (WHO) (1994) expanded case defi-
ition for AIDS surveillance, of whom 6 were dually
nfected. (For a summary of the HIV-1 singly and the
IV-1 and HIV-2 dually infected samples included and
atient characteristics, see Table 1.) HIV-2 singly infected
ontrol subjects consisted of a group of asymptomatic
ndividuals (n 5 20) as well as patients with AIDS (n 5
1), as included in a previous report (Norrgren et al.,
997).
IV serology and diagnostic PCR
All samples were screened with the use of an enzyme-
inked immunosorbent assay (ELISA) (Enzygnost anti-
IV-1/HIV-2 Plus; Behring, Marburg, Germany) and con-
irmed by Western blotting; for HIV-1, HIV Blot 2.2 (Diag-
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319MOLECULAR CHARACTERIZATION OF HIV-1 AND -2ostic Biotechnology/Genelabs Diagnostics, Science
ark, Singapore) was used, and for HIV-2, a previously
escribed in-house assay (Albert et al., 1987) was used.
he WHO (1990) criteria for WB positivity requiring reac-
ivity with at least two env bands were applied. All sam-
les positive by both HIV-1 and HIV-2 Western blotting
ere further tested for differentiation between HIV-1 and
IV-2 by an ELISA based on separate synthetic peptides
erived from the transmembrane proteins of HIV-1
nd HIV-2 (PEPTI-LAV 1-2; Sanofi Diagnostics Pasteur,
arnes-La-Coquette, France) according to a strategy
escribed previously (De Cock et al., 1991). Evaluations
f the HIV antibody testing strategy in Bissau have
hown a high concordance between the results obtained
y serology and by PCR and a high degree of distinction
etween HIV-1 and HIV-2 (Andersson et al., 1997). Sam-
les that were HIV-1 singly or HIV-1 and HIV-2 dually
ositive by the above-described diagnostic strategy, in-
luding Western blotting and PEPTI-LAV 1-2, were sub-
ected to PCR testing, as described previously (Walther et
l., 1999). Briefly, primer sets for the diagnostic nested
CR system were designed to cover two gene regions of
IV-1 and HIV-2, respectively: for HIV-1, the vif (primers
G462, OG465, OG485, OG502) and pol (JA79, JA80, JA81,
A82) regions (Lyamuya et al., 1997), and for HIV-2, the
ag (OG539, OG573, OG759, OG810) and LTR (OG120,
G161, OG288, OG331) regions (Walther et al., 1998).
epeated positive reactions with one of the regions was
onsidered a positive result. One individual (PK 1484)
ho was HIV-1 and HIV-2 dually infected by antibody
ests was only HIV-1 positive by PCR (diagnostic PCR as
ell as PCR for sequencing).
irect population DNA sequencing
For HIV-1, a 410-bp fragment of the env region corre-
ponding to the V3 domain and flanking regions was
CR amplified directly from lysates of uncultured periph-
ral blood mononuclear cells with nested primers (JA167
hrough JA170), as described previously (Leitner et al.,
996). The 59 half (770 bp) of the HIV-1 RT domain of the
ol gene was amplified with nested primers JA99, JA100,
IT136, and RIT137 (Wahlberg et al., 1994). The HIV-2 V3
omain (391 bp) was amplified with nested primers
A163 through JA166 (Norrgren et al., 1997).
The PCR products representing the virus populations
n the peripheral blood mononuclear cell samples were
irectly sequenced on both DNA strands using FITC-
abeled inner PCR primers and a cycle sequencing kit
Thermo Sequenase fluorescent labeled primer cycle
equencing kit; Amersham Pharmacia Biotech, Amer-
ham Place, UK). The sequencing fragments were re-
olved on ALF sequencers (Pharmacia LKB Biotech,
ppsala, Sweden).hylogenetic analyses
The DNA sequences were aligned manually with the
id of the sequence editor in the GDE (Genetic Data
nvironment) package (Smith, 1992). The sequences
rom Guinea-Bissau were compared with sequences
vailable at the Los Alamos Database in December 1998
hrough use of the search tools at the database website
http://hiv-web.lanl.gov). The HIV-1 V3 sequences in-
luded recommended reference sequences for all sub-
ypes (Leitner et al., 1997); all complete subtype A and G
nv genes; selected subtype A/G recombinant se-
uences including IbNG, DJ263, and DJ264; and all avail-
ble V3 sequences from other West African countries
i.e., Benin (n 5 20), Burkina Faso (n 5 1), the Ivory Coast
n 5 14), the Gambia (n 5 4), Ghana (n 5 6), Nigeria (n 5
), and Senegal (n 5 2)]. No sequences were available
rom Cape Verde, Guinea, Liberia, Mali, Mauritania, Ni-
er, Sierra Leone, and Togo. The HIV-1 RT sequences
ere compared with recommended subtype reference
equences (Leitner et al., 1997), all available African
ubtype A and G pol gene sequences, and IbNG, DJ263,
nd DJ264. The HIV-2 V3 sequences were compared with
ll sequences included in the HIV-2/SIVsmm env gene
lignment as well as earlier obtained sequences from
uinea-Bissau (Norrgren et al., 1997). Phylogenetic infer-
nce was done using the PHYLIP package version 3.52c
Felsenstein, 1993). The PHYLIP programs DNADIST us-
ng maximum-likelihood (i.e., F84) distances together
ith NEIGHBOR (neighbor joining) were used to create
rees, SEQBOOT was used to bootstrap data infiles,
here 1000 sets were made, and CONSENSE was used
o compute consensus neighbor-joining trees. To visual-
ze and graphically edit the trees, the program TREE-
OOL (Version 1.0) in GDE was used. The sequences
ave been deposited in GenBank.
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